Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2019 Filed May 3, 2019 20:58 UTC |
King SashaChief Commercial Officer
|
SaleCommon Stock | 1,250 | $29.50 | $36,875.00 |
DisclosureSEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 3 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,594 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:58 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 417 | $6.31 | $2,631.27 |
DisclosureSEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 2 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:58 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 833 | $5.90 | $4,914.70 |
DisclosureSEC source: 0000899243-19-012103 · doc4.xml · nonDerivative · entry 1 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,931 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,069 Underlying: Common Stock · 14,931 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/72nd of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,245 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 7 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 30,245 shares Expires 2027-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,824 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · derivative · entry 6 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Underlying: Common Stock · 4,824 shares Expires 2024-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in three equal installments based upon the Issuer's achievement of certain performance goals as follows: (i) one third vest upon the Issuer's determination, which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved $10 million of total cumulative sales of Allosure, its proprietary next-generation sequencing-based test to detect donor-derived, cell-free DNA after transplantation, commencing after the completion of the offer by the Issuer to exchange certain outstanding stock options for new options as more fully described in the Schedule TO-I, filed with the Securities Exchange Commission on October 12, 2017, as amended, and supplemented on October 24, 2017 and November 9, 2017 (the "Exchange Offer"), (ii) one third vest upon the Issuer's determination, F4 · derivative.exercise_date: (Continued from footnote 3) which has been reviewed by the Issuer's independent registered public accounting firm, that the Issuer has achieved quarterly revenues of at least $18.75 million for two consecutive fiscal quarters commencing after the completion of the Exchange Offer, and (iii) one third vest in the event the closing sales price of the Issuer's common stock is at or above $5.00 per share, as quoted by NASDAQ, for 10 consecutive trading days after the completion of the Exchange Offer. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 14,931 | $2.80 | $41,806.80 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 30,245 | $2.30 | $69,563.50 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 17, 2019 Filed Apr 18, 2019 23:52 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 4,824 | $5.49 | $26,483.76 |
DisclosureSEC source: 0000899243-19-010921 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 01:33 UTC |
Bickerstaff GeorgeDirector
|
OtherWarrant (right to buy) · Derivative | 4,415 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000899243-19-010853 · doc4.xml · derivative · entry 3 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,415 shares Expires 2023-06-17 Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 01:33 UTC |
Bickerstaff GeorgeDirector
|
OtherCommon Stock | 4,415 | $1.12 | $4,944.80 |
DisclosureSEC source: 0000899243-19-010853 · doc4.xml · nonDerivative · entry 1 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,382 Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 01:33 UTC |
Bickerstaff GeorgeDirector
|
PurchaseWarrant (right to buy) · Derivative | 4,415 | $28.26 Strike: $1.12 | $124,767.90 |
DisclosureSEC source: 0000899243-19-010853 · doc4.xml · derivative · entry 2 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,415 Underlying: Common Stock · 4,415 shares Expires 2023-06-17 Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,833 | $0.00 Strike: $6.31 | $0.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 11 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,167 Underlying: Common Stock · 5,833 shares Expires 2028-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 10 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,833 Underlying: Common Stock · 4,167 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 416 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 9 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,028 Underlying: Common Stock · 416 shares Expires 2027-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,041 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 8 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Underlying: Common Stock · 1,041 shares Expires 2027-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,250 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · derivative · entry 7 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,250 shares Expires 2027-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
SaleCommon Stock | 10,000 | $29.81 | $298,064.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 6 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,594 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $31.43, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,833 | $6.31 | $36,806.23 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 5 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,167 | $5.90 | $24,585.30 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 4 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 416 | $2.80 | $1,164.80 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 3 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,041 | $1.07 | $1,113.87 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 2 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 19:48 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,250 | $1.00 | $1,250.00 |
DisclosureSEC source: 0000899243-19-010617 · doc4.xml · nonDerivative · entry 1 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 12, 2019 Filed Apr 12, 2019 23:48 UTC |
Maag PeterDirector · See Remarks
|
SaleCommon Stock | 100,000 | $29.11 | $2,910,530.00 |
DisclosureSEC source: 0000899243-19-010618 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,406 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.31 to $31.51, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,255 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 8 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,745 Underlying: Common Stock · 2,255 shares Expires 2027-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 35,381 | $0.00 Strike: $5.27 | $0.00 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 7 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,369 Underlying: Common Stock · 35,381 shares Expires 2026-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 22, 2017 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 42,364 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · derivative · entry 6 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,364 shares Expires 2025-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 21, 2016 and 1/48th of the shares subject to the option vested monthly thereafter. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 2,255 | $2.30 | $5,186.50 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 3 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 35,381 | $5.27 | $186,457.87 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 09, 2019 Filed Apr 10, 2019 01:43 UTC |
Maag PeterDirector · See Remarks
|
Exercise / conversionCommon Stock | 42,364 | $6.49 | $274,942.36 |
DisclosureSEC source: 0000899243-19-010428 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:27 UTC |
SNYDERMAN RALPHDirector
|
GrantCommon Stock | 343 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009900 · doc4.xml · nonDerivative · entry 1 SNYDERMAN RALPH · CIK 0001178031 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,184 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:32 UTC |
Goldberg MichaelDirector
|
GrantCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009905 · doc4.xml · nonDerivative · entry 1 Goldberg Michael · CIK 0001366412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,546 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| April 01, 2019 Filed Apr 4, 2019 00:27 UTC |
Bickerstaff GeorgeDirector
|
GrantCommon Stock | 514 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-009901 · doc4.xml · nonDerivative · entry 1 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,967 F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
OtherWarrant (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 6 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-06-17 Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
OtherWarrant (right to buy) · Derivative | 7,980 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 5 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,980 shares Expires 2021-06-17 Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
OtherCommon Stock | 25,000 | $1.12 | $28,000.00 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · nonDerivative · entry 2 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,453 Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
OtherCommon Stock | 7,980 | $1.12 | $8,937.60 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · nonDerivative · entry 1 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,453 Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
PurchaseWarrant (right to buy) · Derivative | 25,000 | $36.14 Strike: $1.12 | $903,500.00 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 4 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-06-17 Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 23:12 UTC |
Bickerstaff GeorgeDirector
|
PurchaseWarrant (right to buy) · Derivative | 7,980 | $36.14 Strike: $1.12 | $288,397.20 |
DisclosureSEC source: 0000899243-19-008750 · doc4.xml · derivative · entry 3 Bickerstaff George · CIK 0001329646 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,980 Underlying: Common Stock · 7,980 shares Expires 2021-06-17 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 01:25 UTC |
Goldberg MichaelDirector
|
SaleCommon Stock | 50,000 | $37.36 | $1,867,825.00 |
DisclosureSEC source: 0000899243-19-007817 · doc4.xml · nonDerivative · entry 1 Goldberg Michael · CIK 0001366412 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,740 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.37 to $38.19, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2019 Filed Mar 12, 2019 21:09 UTC |
Yee James PChief Medical Officer
|
SaleCommon Stock | 7,598 | $35.18 | $267,282.44 |
DisclosureSEC source: 0000899243-19-007399 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,409 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.51 to $35.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 01:15 UTC |
Maag PeterDirector · See Remarks
|
SaleCommon Stock | 50,000 | $34.23 | $1,711,280.00 |
DisclosureSEC source: 0000899243-19-007157 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,406 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.695 to $34.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 18:56 UTC |
Yee James PChief Medical Officer
|
Tax withholdingCommon Stock | 3,685 | $31.64 | $116,593.40 |
DisclosureSEC source: 0000899243-19-006264 · doc4.xml · nonDerivative · entry 2 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,007 F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 18:56 UTC |
Yee James PChief Medical Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006264 · doc4.xml · nonDerivative · entry 1 Yee James P · CIK 0001421336 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,692 F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:57 UTC |
Maag PeterDirector · See Remarks
|
Tax withholdingCommon Stock | 22,311 | $31.64 | $705,920.04 |
DisclosureSEC source: 0000899243-19-006266 · doc4.xml · nonDerivative · entry 2 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,406 F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:57 UTC |
Maag PeterDirector · See Remarks
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006266 · doc4.xml · nonDerivative · entry 1 Maag Peter · CIK 0001613855 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,717 F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:56 UTC |
Bell Michael BrianChief Financial Officer
|
SaleCommon Stock | 13,000 | $31.36 | $407,742.40 |
DisclosureSEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 3 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,290 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.495, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:56 UTC |
Bell Michael BrianChief Financial Officer
|
Tax withholdingCommon Stock | 11,770 | $31.64 | $372,402.80 |
DisclosureSEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,290 F2 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:56 UTC |
Bell Michael BrianChief Financial Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006263 · doc4.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,060 F1 · shares: The reported securities were represented by restricted performance stock units that were granted on October 20, 2017, 100% of which vested on March 1, 2019 upon the achievement of the requisite performance criteria. Read SEC document |
| February 22, 2019 Filed Feb 22, 2019 21:36 UTC |
King SashaChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000899243-19-004606 · doc4.xml · derivative · entry 3 King Sasha · CIK 0001721150 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 7,500 shares Expires 2027-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.